Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors

Journal of Cancer Survivorship : Research and Practice
M EndoNaohito Yamaguchi

Abstract

More employees are experiencing a cancer diagnosis during their working-age years, yet there have been no large-scale Japanese studies investigating sick leave due to cancer. We clarified differences in the cumulative partial and full return to work (RTW) rates between different cancer types among Japanese cancer survivors. Data on Japanese employees who experienced an episode of sick leave due to clinically certified cancer diagnosed between 1 January 2000 and 31 December 2011 were obtained from an occupational health register. Subject outcomes within the 365-day period following their initial day of sick leave were utilized for this study. We investigated the cumulative partial/full and full RTW rates by using survival analysis with competing risks and predictors of time to RTW by a Fine-Gray proportional hazard regression model. One thousand two hundred seventy-eight subjects (1033 males and 245 females) experienced their first episode of sick leave due to cancer during the 12-year follow-up period. Of the subjects, 47.1% returned to work full time within 6 months of their initial day of sick leave absence, and 62.3% by 12 months. The cumulative RTW rate varied significantly by cancer type. There were considerable difference...Continue Reading

References

Mar 29, 2002·Psycho-oncology·Evelien R SpeltenJos H A M Verbeek
Jul 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E R SpeltenM A G Sprangers
Feb 9, 2005·Cancer·Pamela Farley ShortKaan Tunceli
Jan 10, 2006·Cancer·Julienne E BowerThomas R Belin
May 15, 2007·Acta Oncologica·T Taskila, M L Lindbohm
Jun 19, 2007·Scandinavian Journal of Work, Environment & Health·Karl Bang ChristensenTage S Kristensen
Aug 24, 2007·The Lancet Oncology·Arduino VerdecchiaUNKNOWN EUROCARE-4 Working Group
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Ziv AmirKaren Luker
Jan 10, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvia FrancisciUNKNOWN EUROCARE Working Group
Jan 7, 2010·Journal of Occupational Rehabilitation·C A M RoelenA J van der Beek
Feb 2, 2010·Critical Reviews in Oncology/hematology·Anja Mehnert
Mar 17, 2010·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Inge HenselmansAdelita V Ranchor
Aug 28, 2010·Occupational and Environmental Medicine·S J TammingaM H W Frings-Dresen
Oct 15, 2010·Journal of Cancer Survivorship : Research and Practice·Michael FeuersteinXinhua Yu
Dec 15, 2010·Journal of Occupational Rehabilitation·C A M RoelenA J van der Beek
Apr 12, 2011·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Marie NilssonKristina Alexanderson
Apr 12, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Katarina SjövallIngemar F Petersson
Jun 10, 2011·Journal of Occupational and Environmental Medicine·Maite SampereFernando G Benavides
Nov 17, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Steffen TorpAlv A Dahl
Mar 17, 2012·Scandinavian Journal of Work, Environment & Health·Anja Mehnert, Uwe Koch
Jan 3, 2013·European Journal of Cancer Care·P van MuijenA J van der Beek
Jan 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia MarinoAnne-Gaelle Le Corroller-Soriano
Jun 27, 2013·Journal of Cancer Survivorship : Research and Practice·Peter van MuijenJohannes R Anema
Jan 17, 2014·Journal of Occupational Health·Nobue SaitoTakashi Muto
Feb 8, 2014·Japanese Journal of Clinical Oncology·Ayako MatsudaUNKNOWN Japan Cancer Surveillance Research Group
Jul 21, 2014·Journal of Occupational Rehabilitation·Kenneth MurraySteven S Sadhra

❮ Previous
Next ❯

Citations

Jul 20, 2016·Industrial Health·Keisuke KuwaharaUNKNOWN Japan Epidemiology Collaboration on Occupational Health Study Group
Nov 14, 2019·Journal of Cancer Survivorship : Research and Practice·Motoki EndoKazuhiko Hayashi
Feb 25, 2020·Head & Neck·Brith GranströmUNKNOWN Swedish Head and Neck Cancer Register (SweHNCR)
Apr 27, 2019·International Journal of Environmental Research and Public Health·Atsuhiko OtaHiroshi Yatsuya
Dec 20, 2019·Journal of Neuro-oncology·Akihito YoshidaToshihiko Wakabayashi
Nov 3, 2017·Journal of Epidemiology·Motoki EndoNaohito Yamaguchi
Mar 28, 2020·European Journal of Cancer Care·Ariane Mamguem KamgaTienhan Sandrine Dabakuyo-Yonli
May 29, 2018·International Archives of Occupational and Environmental Health·Motoki EndoNaohito Yamaguchi
Nov 20, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Humayra RashidSusanne Singer
Nov 17, 2020·Frontiers in Human Neuroscience·Fabiola SilvaggiSilvia Schiavolin
Mar 26, 2021·The Journal of Obstetrics and Gynaecology Research·Motoki Endo
Apr 28, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Flora VayrFabrice Herin

❮ Previous
Next ❯

Software Mentioned

EZR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.